Brief: Homology Medicines Q2 net income USD -35.044 million
14/08/2023 23:24
Aug 14 (Reuters) - Homology Medicines Q2 collaboration revenue USD 354 thousand. * Q2 net income USD -35.044 million * Q2 operating expenses USD 31.17 million * Q2 pretax profit USD -29.305 million * Q2 income from operations USD -30.816 million * Q2 basic EPS USD -0.61
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview